Medical Park Pharmacy (MPRX Inc.), Dallas, TX
Is Medical Park Pharmacy (MPRX Inc.) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility, with FDA’s note “Out of business”.
Does Medical Park Pharmacy (MPRX Inc.) hold a Texas pharmacy license?
No license with this exact name and city was found in the Texas State Board of Pharmacy file dated Nov 15, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed.
Has Medical Park Pharmacy (MPRX Inc.) had a state board action or FDA letter?
FDA letters: no matching record found on FDA’s compounding inspections and actions page (current as of Oct 22, 2026, covering 2019 on) on Nov 15, 2026; the page lists 1 Form 483 (Nov 22, 2019) for Medical Park Pharmacy (MPRX Inc.). Texas board disciplinary orders: not checked, because the board’s file flags orders only on a license, and no license matched this name and city.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- MPRX Inc.; Medical Park Pharmacy
- Location
- Dallas, TX
- Type as FDA labels it
- 503A
- FDA’s note
- Out of business
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Nov 22, 2019
- FDA Data Dashboard inspections
- 1 inspection: 1 OAI; 1 published Form 483
- Form 483 text on this page
- 1 Form 483, 4 observations
- State board records
- No exact match
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as MPRX Inc., dba Medical Park Pharmacy, a 503A facility, with 1 dated action.
| Document | |||
|---|---|---|---|
| Nov 22, 2019 | Form 483 | 483 Issued 11/22/2019 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists MPRX, Inc., Dallas, TX (FEI number 3004102002), matched to this page by exact name, city and state. It lists 1 inspection: 1 OAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Nov 22, 2019 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3004102002 | 1110724 |
Form 483s FDA has published for this site
- Nov 22, 2019: Form 483 to MPRX, Inc., published Jan 7, 2020. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 4 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Nov 18, 2019 to Nov 22, 2019: 4 observations
- Firm on the cover
- MPRX, Inc. dba Medical Park Pharmacy, 8230 Elmbrook Dr Ste 600B, Dallas, TX 75247-4144
- FEI number
- 3004102002
- Establishment type on the cover
- Producer of Non-Sterile Drugs
- FDA district office on the cover
- 4040 North Central Expressway, Suite 300 Dallas, TX 75204
- Matched to this page by
- FEI number on the cover; linked from actions page, Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
Your firm released drug product in which the strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.
Specifically, during my review of your October 2019 Formula Worksheets, <Redacted B4> of <Redacted B4> lots of products were produced using at least one expired bulk drug substance/chemical including, but not limited to the following: Phenylephrine, Desonide, Dexamethasone, Liothiyonine, Acesulfame Potassium, Gabapentin and Cyclobenzaptine.
Observation 2
Calibration of mechanical equipment is not performed daily or an a routine schedule designed to assure proper performance.
Specifically,
a) You have not calibrated the scale used to weigh bulk drug substances/chemicals since you moved to this location.
b) You stated, and I observed you do not verify the weighing of ingredients/components for each lot made.
c) Formula Worksheets do not list ingredients and the quantity of each in the order of the manufacturing process.
Observation 3
You produced highly potent drugs without providing adequate to prevent cross-contamination.
Specifically, you do not document the cleaning of the <Redacted B4> hood and the hood used and non-dedicated equipment (i.e. <Redacted B4> etc.) to demonstrate control of cross contamination between highly potent drugs.
Observation 4
Vermin was observed in your production area.
Specifically, on November 20, 2019, I observed an insect in the pharmacy area on the floor where compounding activities occur.
State board of pharmacy records
No license with this exact name and city was found in the Texas State Board of Pharmacy file dated Nov 15, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. Board file.
What this covers: The file marks whether a license has prior disciplinary orders (column DISP ACTN, Y or N) but does not list them; the orders are on the board’s license lookup, which this index does not copy. The board says orders entered more than 10 years ago are not online.
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Texas State Board of Pharmacy license file
- Texas State Board of Pharmacy disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.